Researching the Added Value of Behavior-Based Qualitative Experiential Data to a Survey Based Questionnaire in Establishing a Patient Experience Charter at the Walker Family Cancer Center

This paper explores how the commonalities of electronic patient experience measurement with first person narrative collection had a potentially high reliability of being a complementary process. Niagara Health believe it captured far more data by including an authentic exploration of the experience of both patients and providers in their different healthcare delivery model in Ontario. The report also provides an in-depth exploration of the inherent problem of ‘normalizing’ the passive recipient of care. This strategy provides a forum that can be replicated throughout all disciplines of care by encouraging all that we must do more to normalize the behaviors of the knowledgeable partners of care in Ontario.
Related content
-
Policy & Measurement
Policy & Measurement: The Impact of Patient & Family Involvement
By Rosie Bartel This is the sixth blog in a series of eight by The Beryl Institute’s Global Patient & Family Advisory Board (GPFAB). The intent of this series is to present our perspective on patients’ and families’ lived experience through each of the strategic lenses of The Beryl Institute’s Experience Framework. The Experience Framework
Learn more -
Policy & Measurement
Listening to the Unsaid: Utilizing Patient-Reported Outcome Measures (PROMs) to Manage the Dental Anxiety of a Special Child
This article is the journey of a dentist who adopted the additional role of a healthcare manager and embarked on a transformative journey to enhance the realm of pedodontics.
Learn more -
Policy & Measurement
Leveraging patient experience measures as surrogate outcomes to evaluate health care interventions
Patient experience quality measure scores are widely accepted as outcomes in health services research. For some patients and in some settings, such as hospice care, they can be the most important outcomes. While these measures are widely used, the potential to use them as surrogate outcomes in a clinical trial sense has gone under-recognized. The
Learn more